Relay Therapeutics (NASDAQ:RLAY – Get Free Report) and BioLineRx (NASDAQ:BLRX – Get Free Report) are both healthcare companies, but which is the better investment? ProfitabilityThis table compares Relay Therapeutics and BioLineRx’s net margins, return on equity and return on assets. Get Relay Therapeutics alerts:Net Margins Return on Equity Return on Assets Relay Therapeutics N/A -47.23% -43.10% BioLineRx -563.70% -37.73% -19.42%Institutional & Insider Ownership97.0% of Relay Therapeutics shares are owned by institutional investors. Analyst RecommendationsThis is a summary of current ratings and price targets for Relay Therapeutics and BioLineRx, as provided by MarketBeat. Given Relay Therapeutics’ stronger consensus rating and higher possible upside, research analysts clearly believe Relay Therapeutics is more favorable than BioLineRx.